Telangana, India

Nangunoori Sampath Kumar

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nangunoori Sampath Kumar. Retrieved from https://idiyas.com/inventor/nangunoori-sampath-kumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Nangunoori Sampath Kumar

Introduction

Nangunoori Sampath Kumar is a notable inventor based in Telangana, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for specific protein kinases. With a total of 2 patents to his name, his work has implications for various therapeutic applications.

Latest Patents

Kumar's latest patents focus on CaMKII inhibitors and their uses. The present invention provides compounds that are useful as inhibitors of Ca/calmodulin-dependent protein kinase (CaMKII), along with compositions and methods for utilizing these compounds effectively. This innovation holds promise for advancing treatments in related medical fields.

Career Highlights

Nangunoori Sampath Kumar is affiliated with The Johns Hopkins University, where he continues to engage in groundbreaking research. His work is characterized by a commitment to exploring new avenues in protein kinase inhibition, which is crucial for understanding various cellular processes.

Collaborations

Some of his notable coworkers include Daniel Emil Levy and Howard Schulman. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Nangunoori Sampath Kumar's contributions to the field of biochemistry through his innovative patents exemplify the impact of research on medical advancements. His work continues to inspire future innovations in the realm of protein kinase inhibitors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…